Clinical Trial Update: Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating intratumoral injections of two natural killer cell products for skin cancers (basal cell carcinoma and squamous cell carcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Squamous Cell Carcinoma of the Skin

Drugs mentioned

• Standard Universal Donor Expanded Natural Killer Cells
• TGF-beta Imprinted Natural Killer Cells

Snippet

Sponsor: Kirsten Johnson | Conditions: Skin Basal Cell Carcinoma, Skin Nodular Basal Cell Carcinoma | EARLY_Phase 1 | Status: RECRUITING